Patrick Hoegen
About Patrick Hoegen
Patrick Hoegen is the Associate Director of Pharmacovigilance Vendor Management at Alkermes in Waltham, Massachusetts, with extensive experience in drug safety and risk management.
Company
Patrick Hoegen is currently employed by Alkermes, a biopharmaceutical company focusing on developing innovative medicines for the treatment of central nervous system diseases and rare diseases. Alkermes is based in Waltham, Massachusetts, United States.
Title
Patrick Hoegen holds the title of Associate Director, Pharmacovigilance Vendor Management at Alkermes. In this role, he oversees the management of relationships with vendors who provide services related to pharmacovigilance, ensuring compliance with company standards and regulatory requirements.
Education and Expertise
Patrick Hoegen acquired his Bachelor of Science Degree in Business Administration from Eastern Nazarene College, where he studied from 1998 to 2000. His expertise spans across various areas, including pharmacovigilance, drug safety, risk management, and operations management.
Professional Background
Patrick Hoegen has an extensive professional background with diverse roles. He previously served as Director, Enterprise Learning and Development, and Director, PV Quality and Compliance at Alkermes. Before Alkermes, he worked at Biogen as Senior Manager, Safety and Benefit Risk Management, and Manager, Drug Safety and Risk Management. Patrick also held positions at Danaher Corporation, Ruland Manufacturing Co., Intel Corporation, and the United States Air Force.
Achievements and Projects
Patrick Hoegen has led notable projects, including the development and implementation of key performance indicator processes at Alkermes. He managed strategic vendor selection through a Request for Proposal process and was an operational project co-lead for the implementation of the FDA combination reporting process and the ARGUS database upgrade. Additionally, he played a crucial role in inspection readiness activities, ensuring quality standards and timely completion of CAPAs.